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ABSTRACT Targetoid hemosiderotic hemangioma is an acquired vascular malfor-
mation of unknown origin. We report the case of a 31-year-old man with a recur-
rent and spontaneous regressive targetoid hemosiderotic hemangioma. Diagnosis 
relied on clinical and histological findings. Physical examination revealed presence 
of an approximately 2 cm targetoid lesion located on the left arm, and associat-
ed with pain after pressure. No trigger agent (trauma, insect sting) was reported. 
Dermoscopy showed a group of red lacunae centrally, encircled by an intermedi-
ate yellow circular homogenous area and a red violaceous homogenous ring in 
the periphery. The histopathological examination and the immunohistochemical 
staining of the lesion were characteristic for a hemangioma-like proliferation of 
vessels in the upper part of the dermis, similar to a targetoid hemosiderotic an-
gioma. We also review epidemiological, clinical, and histopathological findings in 
6 similar cases presented in the literature. Spontaneous regression and recurrence 
have rarely been described in this type of skin lesion.
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INTRODUCTION
Targetoid hemosiderotic hemangioma (hobnail 
hemangioma) is a rare benign vascular tumor de-
scribed for the first time in 1988. The female-to-male 
ratio reported in the literature is 1:1, with an age of 
onset ranging from 5 to 67 years (1). 
The etiology of this disease is incompletely elu-
cidated. A commonly accepted theory is that it may 
occur on a pre-existing hemangioma, after a trauma. 
Trauma could induce the formation of thrombi and 
microshunts, with pressure from the capillaries caus-
ing the filling of the lymph spaces with erythrocytes, 
contributing to the formation of aneurysmal micro-
structures. The obstruction of some lymphatic vessels 
could induce inflammation, fibrosis, and interstitial 
hemosiderin deposits (2). The targetoid appearance 
could be explained by hemorrhage from the vascular 
proliferation, causing a purpuric ring with hemosid-
erin deposits.
The diagnosis relies on clinical and histological 
findings. Clinically, hemosiderotic hemangioma typi-
cally appears as a solitary small targetoid lesion with 
a central red/ purple and/or brown papule, encircled 
by a pale area and peripheral ecchymotic ring. It is 
usually located on the limbs and trunk, but unusual 
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presentation on the scalp has also been described (3). 
Clinical differential diagnosis includes Kaposi’s sarco-
ma, hemangioma, dermatofibroma, melanocytic ne-
vus, insect bite reaction, and solitary angiokeratoma 
(4). 
Dermoscopy most frequently shows centrally lo-
cated red lacunae and a homogenous red-violaceous 
area in the periphery. Some lesions may also present 
a delicate pigmented network in the periphery (5). 
Histologically, hemosiderotic hemangioma pres-
ents a non-circumscribed dermal vascular prolifera-
tion with thin-walled dilated vessels in the papillary 
dermis continued with narrower, slit-like endothelial 
lined spaces in the deep reticular dermis, dissect-
ing between dermal collagen bundles. Extravasated 
erythrocytes and hemosiderin deposits can be ob-
served in the dermis. An inflammatory lymphocytic 
interstitial or perivascular infiltrate is often seen. The 
lymphatic origin of targetoid hemosiderotic angio-
mas has been confirmed by recent studies, which 
demonstrated the positive immunohistochemical 
staining of these lesions for CD31, vascular endothe-
lial growth factor receptor-3 (VEGFR-3), the lymphat-
ic specific antipodoplanin monoclonal antibodies 
(D2-40), and also a lack of CD34 staining. The absent 
or minimal proliferative nature of this vascular lesion 
has been suggested by a consistent very low Ki-67 
proliferation index. The histopathologic differential 
diagnosis includes patch stage and lymphangioma-
like variants of Kaposi’s sarcoma, well-differentiated 
angiosarcoma, retiform hemangioendothelioma, 
Dabska tumor, and benign lymphangiomas. In con-
trast to Kaposi sarcoma, targetoid hemosiderotic 
angioma does not stain positively for human herpes-
virus 8 (6).
The evolution of this benign tumor is different. It is 
permanent in most of the cases, and it is generally ac-
cepted that it does not resolve itself. An excision may 
be indicated, if the lesion is cosmetically disturbing 
(7). To our best knowledge, there are only a few case 
reports of targetoid hemosiderotic hemangioma with 
recurrent evolution in the literature (4,7,8). 
CASE REPORT
A 31-year-old male patient from an urban area 
presented in our department in August 2016, with a 
1-week history of spontaneous occurrence of a targe-
toid lesion, located on the left arm (Figure 1, A). He 
also reported pain on pressure. The patient reported 
that the lesion had occurred one year before, approx-
imately 2-3 times, in the same place. The lesion had 
an approximate duration of 10 days and then disap-
peared completely between cycles. The skin in the 
region looked normal, without evidence of a papule, 
postinflammatory hyperpigmentation, or scarring. 
Personal medical history was not significant. 
Figure 1. Clinical, dermoscopy, and histopathological features of our patient at diagnosis. (A) Clinical aspect at diagnosis. (B) 
Dermoscopy at diagnosis. (C) Clinical aspect after regression. (D) Histopathological aspect, low magnification. € Histopatho-
logical aspect, high magnification. Hobnail endothelial spaces in the center of the lesion.
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Physical examination revealed the presence of an 
approximately 2 cm targetoid lesion with a central 
red papule, encircled by a pale area and a peripheral 
ecchymotic ring, located on the left arm. Dermosco-
py showed a group of red lacunae centrally, encircled 
by an intermediate yellow circular homogenous area 
and a red violaceous homogenous ring in the periph-
ery (Figure 1, B).
Histopathologic examination was performed on 
two samples. The histopathological examination of 
the sample from the middle of the lesion showed a 
slightly irritated epidermis. In the dermis, we observed 
slit-like proliferations of vessels, with prominent endo-
thelium in some places, erythrocytes, a sparse inflam-
matory infiltrate, and few plasma cells (Figure 1, D, 
E). The histopathological examination of the sample 
from the margin showed a very sparse finding, with 
few erythrocytes and few prominent vessels. The im-
munohistochemical staining of the sample from the 
middle showed positive staining of the vessels from 
the dermis for CD31, positive staining of some ves-
sels for D2-40 (podoplanin), and negative staining for 
HHV8. Actin (alpha smooth muscle) staining showed 
muscular differentiated cells around the vessels. MIB1 
staining showed no obviously proliferating endothe-
lium. Therefore, the lesion was evaluated as a heman-
gioma-like proliferation of vessels in the upper part 
of the dermis. The histology was similar to a targetoid 
hemosiderotic angioma.
No local or systemic treatment was administered. 
The hemangioma completely disappeared without 
leaving any scar a few days after the punch biopsy 
from the middle and margin of the lesion was per-
formed (Figure 1, C). 
The patient was contacted after 22 months. He re-
ported no new occurrence of the lesion.
REvIEW OF LITERATURE
We have also performed a review of the literature. 
The PubMed database was searched for the following 
terms: “targetoid”, “hemosiderotic”, “hemangioma”, 
“recurrent”, “regressive”.
We reviewed a total number of 6 cases with recur-
rent targetoid hemosiderotic hemangioma. The clini-
cal and histopathological features of the patients are 
shown in Table 1. 
DISCUSSION
Targetoid hemosiderotic hemangioma may rep-
resent a transient inflammatory phase in the natural 
evolution of a capillary hemangioma (4). These lesions 
generally persist, and no treatment is recommended. 
Excision is recommended in case of esthetic issues. 
Spontaneous total regression and cyclic changes, 
such as swelling and intermittent changes in lesion 
size and rim without complete regression, have been 
reported in association with menstruation (4) or in 
children (6).
Regression represents a common feature in infan-
tile capillary hemangiomas. This event is supposed to 
be caused by apoptosis, as a higher number of apop-
totic cells was found in these hemangiomas, com-
pared to lobular capillary hemangioma. Regression 
was also reported in tufted angiomas (9). 
We report the case of a 31-year-old man with a re-
current targetoid hemosiderotic angioma, appearing 
and disappearing in the same place without leaving 
any scars. The patient reported 2-3 similar episodes in 
the past year. No trigger agent (trauma, insect sting) 
was reported. 
To our best knowledge, there are only 6 cases of 
recurrent targetoid hemosiderotic hemangioma re-
ported in the literature (see Table 1). The age of the 
patients ranged between 9 and 40 years. Trauma (bee 
sting) was incriminated as a potential trigger in only 
one patient (case 5) (Table 1). Occurrence at men-
struation was mentioned in the same patient (case 5) 
(Table 1). The lesions were situated on the trunk in 2 
patients (case 2 and 5), upper limbs in 3 patients (case 
1, 3, and 6) and lower limbs in 1 patient (case 4). Clini-
cally, all lesions presented a central papule with an 
ecchymotic ring in the periphery in 3 patients (case 1, 
4, 5), an erythematous ring in 1 patient (case 2), and 
a brown-gray macule in 2 patients (case 3 and 6). As 
for associated symptoms, itching and burning were 
present in one patient (case 2). The other patients re-
ported no associated subjective symptoms. In histo-
pathological examination, the patients demonstrated 
histopathological characteristics already described in 
previous publications, as mentioned in Table 1. We 
could not identify any specific epidemiological, clini-
cal, or histopathological findings that could explain 
the recurrence of the lesions in the 6 reported cases.
There are a few speculative theories on recurrence 
of such lesions in the literature. The cyclic changes 
related to menstruation could be the result of fluc-
tuation of levels of circulating estrogen, which could 
cause instability of vessels and leakage (4). Another 
possible explanation could be trauma. None of these 
factors were identified in our patient. Additionally, a 
statistically significant larger size has been reported 
in targetoid hemosiderotic hemangiomas with epi-
sodic changes compared with persistent lesions (4).
Therefore, the reason for the recurrence and cyclic 
changes of this fascinating lesion remains a mystery. 
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Superficial dermis: dilated 
and proliferated capillaries, 
with hobnail endothelial cells 
protruding into the lumen, 
parallel to the skin surface. 
Congested highly dilated 
lumens filled with eosinophilic, 
homogenous materials. Mid-
dermis: slit-like vessels dissecting 
between collagen bundles. 
Wide amounts of extravasated 
erythrocytes and hemosiderin 
deposition in the dermis. 





cycles every 4 
to 5 months 
in the last 
past 4-5 years
6 mm violaceous 
papule 
with a surrounding 




Removal of the lesion by 
elliptical excision.










few months in 
the last past 4 
years
Tan-gray, 1 cm 




Removal of the lesion by 
elliptical excision.
Epidermal hyperplasia. Dermis: 
wedge-shaped vascular tumor 
with vascular ectasias, slit-like 
spaces, lymphangiectasias 








2 cycles in the 
last 2 years
Enlarging, non-
tender 9 mm, black 




Removal of the lesion by 
elliptical excision.
Diagnostic features of a 
targetoid hemosiderotic 
hemangioma and a foreign body 
type giant cell reaction 
5 
(4)
F 40 Bee sting Left side of 
the upper 
back








from a white-tan 5 
mm papule to a deep 
black 14 mm papule 
with an ecchymotic 
ring every other 
menses
No Removal of the lesion by 
elliptical excision.
Features of a targetoid 
hemosiderotic hemangioma. 
Presence of the “promontory 
sign” (lymphangiectasia 
containing island of normal 
vessels surrounded by numerous 
telangiectasias)
6 (10) M 12 Not 
mentioned









In our opinion, physicians should be aware of the 
presence of this rare clinical entity and include it in 
the differential diagnosis of vascular lesions, includ-
ing pediatric cases. 
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